Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rabeprazole vs Lansoprazole in Reflux Esophagitis by CYP2C19 Genotype
NCT01008696Phase 4Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- May 2007
- Primary completion
- Aug 2008
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of rabeprazole in reflux esophagitis, sponsored by Janssen Pharmaceutical. Started May 2007; status: completed.
02
Drugs
rabeprazole
03
Conditions
reflux esophagitis
Beyond the preview
Go deeper on NCT01008696.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01008696.